Patents by Inventor Hossein Nejadnik

Hossein Nejadnik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dual-modality imaging probe for combined localization and apoptosis detection of stem cells
    Patent number: 10188752
    Abstract: A ferumoxytol-based dual-modality imaging probe for long-term stem cell tracking through MRI and early diagnosis of cell apoptosis through simultaneous fluorescence imaging is provided. Specifically, a ferumoxytol-based dual-modality imaging probe is provided with enhanced T2* relaxivity for tracking stem cells through magnetic resonance imaging and detecting apoptotic stem cells through fluorescence imaging.
    Type: Grant
    Filed: August 4, 2017
    Date of Patent: January 29, 2019
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Kai Li, Heike E. Daldrup-Link, Hossein Nejadnik
  • Dual-modality Imaging Probe for Combined Localization and Apoptosis Detection of Stem Cells
    Publication number: 20180036435
    Abstract: A ferumoxytol-based dual-modality imaging probe for long-term stem cell tracking through MRI and early diagnosis of cell apoptosis through simultaneous fluorescence imaging is provided. Specifically, a ferumoxytol-based dual-modality imaging probe is provided with enhanced T2* relaxivity for tracking stem cells through magnetic resonance imaging and detecting apoptotic stem cells through fluorescence imaging.
    Type: Application
    Filed: August 4, 2017
    Publication date: February 8, 2018
    Inventors: Kai Li, Heike E. Daldrup-Link, Hossein Nejadnik
  • Compositions And Methods For Mesenchymal And/Or Chondrogenic Differentiation Of Stem Cells
    Publication number: 20140271616
    Abstract: Chondrocytes and compositions including chondrocytes produced via methods that do not require the formation of embryoid bodies are disclosed herein. The cells and compositions disclosed herein are suitable for use in treating osteoarthritis and other cartilage disorders or injury, as well as for tissue regeneration, particularly cartilage regeneration.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Inventors: Hossein Nejadnik, Olga Lenkov, Heike Daldrup-Link